Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Levi Garraway

Dana Farber Cancer Inst, Department: Na

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Foundation Medicine

Disclosed Value
Listed Reason
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)

Dr. Garraway is a Scientific Advisor for Foundation Medicine, a clinical diagnostics services company that endeavors to create and provide clinical diagnostic tests based on sequencing and other genomics technologies, with a primary focus on the detection and interpretation of “actionable” mutations in cancer. The goal of the colorectal SPORE project is to study why BRAF-mutant colorectal cancers (CRC) do not respond to RAF/MEK inhibition, and to discover new therapeutic avenues that could be exploited to target this genetic subtype of cancer. In Aim 3, this project will involve sequencing of samples from a clinical trial using RAF and MEK inhibitors in BRAF-mutant colon cancer, which could theoretically discover a new gene mutation that would eventually become incorporated into a targeted sequencing panel such as the Foundation test.

Listed Research Project
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER

Public Health Relevance: Building on our progress over the past 5 years, the DF/HCC GI SPORE seeks to translate biological and technological advances into meaningful improvements to prevent, detect early, and manage more accurately and effectively the treatment of GI malignancies.

Filed on September 27, 2013.

Tell us what you know about Levi Garraway's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine >$600,000
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $80,000 - $99,999
Levi Garraway Harvard Medical School Conflict of Interest Foundation Medicine, Inc. $80,000 - $99,999
Levi Garraway Massachusetts General Hospital Conflict of Interest Foundation Medicine $80,000 - $99,999
Levi Garraway Massachusetts General Hospital Conflict of Interest Foundation Medicine Value cannot be readily determined
Levi Garraway Harvard Medical School Conflict of Interest Foundation Medicine, Inc. >$600,000
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $60,000 - $79,999
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $60,000 - $79,999
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine >$600,000
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page